HB-2121

DRUG2 trials

Sponsors

Nielsen Fernandez-Becker

Conditions

Celiac DiseaseHealthy

Phase 1

A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

CompletedNCT07063823

Nielsen Fernandez-BeckerCeliac Disease, Healthy

Start: 2025-08-26End: 2026-04-07Updated: 2026-07-28

A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

RecruitingNCT07377565

Nielsen Fernandez-BeckerCeliac Disease

Start: 2026-04-29End: 2027-06-01Target: 20Updated: 2026-07-28